Cita APA (7a ed.)
Bilinska, A., Kumar, N., Gnesin, S., Läppchen, T., Menéndez, E., Martin, M., . . . Gourni, E. (2026). Preclinical evaluation of DOTAGA.Glu.(FAPI)2 and DO3A.Glu.(FAPI)2 as theranostics with human dosimetry extrapolation to lutetium-177 and terbium-161 analogs. European Journal of Nuclear Medicine & Molecular Imaging, 53(3), 1887-1902.
Cita Chicago Style (17a ed.)
Bilinska, Adrianna, Naveen Kumar, Silvano Gnesin, Tilman Läppchen, Elena Menéndez, Marcel Martin, Frank Rösch, Axel Rominger, y Eleni Gourni. "Preclinical Evaluation of DOTAGA.Glu.(FAPI)2 and DO3A.Glu.(FAPI)2 as Theranostics with Human Dosimetry Extrapolation to Lutetium-177 and Terbium-161 Analogs." European Journal of Nuclear Medicine & Molecular Imaging 53, no. 3 (2026): 1887-1902.
Cita MLA (9a ed.)
Bilinska, Adrianna, et al. "Preclinical Evaluation of DOTAGA.Glu.(FAPI)2 and DO3A.Glu.(FAPI)2 as Theranostics with Human Dosimetry Extrapolation to Lutetium-177 and Terbium-161 Analogs." European Journal of Nuclear Medicine & Molecular Imaging, vol. 53, no. 3, 2026, pp. 1887-1902.
Precaución: Estas citas no son 100% exactas.